- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05747612
Mental Coaching and Counseling for Bipolar Patients: Dealing With Moments of Crisis in Times of COVID-19.
February 27, 2023 updated by: Mazza Marianna, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mental Coaching and Counseling for Bipolar Patients: Dealing With Moments of Crisis in
The goal of this interventional study is to evaluate some outcome parameters at the time of enrollment (T0), during the treatment (T1 and T2) and at the end (T3) of the subjects who will have carried out an individual counseling intervention or mental coaching.
The aim is to determine the incidence of depression, trait anxiety, state anxiety, sleep disorders, resilience, defense mechanisms, distress caused by stressful events in a sample of subjects affected by Bipolar Disorder.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Roma
-
Rome, Roma, Italy, 00168
- Fondazione Policlinico Gemelli IRCCS
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Recruited subjects have a diagnosis of Bipolar Disorder and are 18 years of age or older.
Exclusion Criteria:
- Previous or current intellectual disability in accordance with the Diagnostic and Statistical Manual of Mental Disorders, DSM-5.
- Patients who are unable to express consent and who do not have a caregiver who can give it for them.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patients with Bipolar Disorder
|
Counseling is "the art of helping yourself", that is, a helping relationship based on a series of interventions and stimuli for creativity, aimed at pursuing and maintaining an ever better relational, social and existential quality of life.
Coaching is a fundamentally action-oriented method, aimed at concrete changes, the improvement of performance and the achievement of objectives.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To determine the incidence of depression, trait anxiety, state anxiety, sleep disorders, resilience, defense mechanisms, distress caused by stressful events in a sample of subjects affected by Bipolar Disorder.
Time Frame: 12 months
|
Administration of psychometric scales
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To ascertain the presence of evolutionary and maturational trends in the defensive structure especially in the face of a totally unpredictable and unexpected situation such as the COVID-19 pandemic.
Time Frame: 12 months
|
Administration of psychometric scales
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2020
Primary Completion (Actual)
January 25, 2022
Study Completion (Actual)
February 1, 2023
Study Registration Dates
First Submitted
February 26, 2023
First Submitted That Met QC Criteria
February 26, 2023
First Posted (Actual)
February 28, 2023
Study Record Updates
Last Update Posted (Actual)
March 1, 2023
Last Update Submitted That Met QC Criteria
February 27, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3275
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on To Determine the Incidence of Depression in Subjects Affected by Bipolar Disorder
-
Hospital General Universitario Gregorio MarañonCompletedThe Aim of the Study is to Analyze the Incidence of Trocar Site Hernia (TSH) | in Orifices Created by Trocars Measuring ≥10 mm in Diameter, | and to Determine Whether Closure of the External Fascial Layer Prevents | TSH and Potential Related Complications.Spain
-
Peking UniversityUnknownthe Use of Antidepressants in Patients With Bipolar DepressionChina
-
Synergy Health Concepts, Inc.UnknownTo Determine the Safety and Validity of Venous Angioplasty and | Valvuloplasty in the Treatment of CCSVI. In Addition, it Will | Allow Researchers to Sub-classify Valve Morphology in Relation | to Treatment Success. This Will be Evidenced by Venous Patency | Forty-eight Hours by Doppler... and other conditionsUnited States
-
Assiut UniversityNot yet recruitingTo Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer Institute (SECI)
-
Baskent University Ankara HospitalUnknownTo Investigate the Incidence and Causes of Awareness During General Anesthesia | To Investigate the of Dreaming During Anesthesia | To Investigate the Intra-operative Experiences of Patients Who Report Awareness | To Investigate the Risk Factors That May be Associated With Awareness | To... and other conditionsTurkey
-
Klinikum FloridsdorfMedical University of Vienna; Klinik Favoriten; Salzkammergut Klinikum VöcklabruckCompletedThe Aim of This Study is to Determine the Influence of BMI and Lymph Node Status on OS in CRC Patients in the Long TermAustria
-
University Of PerugiaUnknownThe Primary Study Objective is to Assess the Efficacy and | Safety of Extended 4-week Heparin Prophylaxis Compared to | Prophylaxis Given for 8±2 Days After Planned Laparoscopic | Surgery for Colorectal Cancer. | The Clinical Benefit Will be Evaluated as the Difference in | the Incidence of... and other conditionsItaly
-
AstraZenecaNot yet recruitingUsing NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE
-
OMNI Medical Services, LLCOMNI Medical Services IncRecruitingDepression | COVID-19 | Epilepsy | Multiple Sclerosis | Glaucoma | Cancer | Covid19 | Chronic Pain | Parkinson Disease | Inflammatory Bowel Diseases | Hepatitis C | Insomnia | HIV/AIDS | Amyotrophic Lateral Sclerosis | Fibromyalgia | Anxiety | Bipolar Disorder | Seizures | Crohn Disease | Traumatic Brain Injury | Ulcerative Colitis | Sickle... and other conditionsUnited States
-
Sanguine BiosciencesCompletedDepression | Melanoma | Epilepsy | Lymphoma | Multiple Sclerosis | Kidney Cancer | Cervical Cancer | Diabetes Mellitus | Leukemia | Breast Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Parkinson's Disease | Systemic Lupus Erythematosus | Multiple Myeloma | Hepatitis B | Insomnia | Colorectal Cancer | HIV/AID... and other conditionsUnited States
Clinical Trials on Counseling and Coaching
-
West Virginia School of Osteopathic MedicineNot yet recruitingHeart Failure | Hypertension | Obesity | Polycystic Ovary Syndrome | Metabolic Syndrome | Hyperlipidemias | Coronary Heart Disease | Depression, Anxiety | Type II DiabetesUnited States
-
Paijat-Hame Hospital DistrictPfizer; Tampere University; Sitra, the Finnish Innovation FundUnknownHeart Failure | Coronary Disease | Diabetes Mellitus, Type 2Finland
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
York UniversityUnknown
-
Public Health Management CorporationCenters for Disease Control and PreventionCompletedBisexually-active Men | at Risk for HIVUnited States
-
Johns Hopkins UniversityZanvyl and Isabelle Krieger FundCompleted
-
Duke UniversityDavid Grant U.S. Air Force Medical CenterCompletedPrediabetic State | Coronary Heart Disease, Susceptibility to, 5United States
-
Mayo ClinicCompletedStress | Anxiety | Leadership | Professional Role | Goals | Well-Being | Physician's Role | Professional Burnout | Development, HumanUnited States
-
Rigshospitalet, DenmarkGilead SciencesCompleted